March 2025s Top -Penny shares to be seen

Until March 2025, the US stock market has experienced an increase, which is due to positive developments such as a temporary appearance of tariffs that have an impact on car manufacturers, which led to important indices such as the Dow Jones Industrial Average and S&P 500. Penny shares remain a fascinating option for investors who were looking for opportunities beyond well-known companies beyond well-known companies. Despite their vintage label, these shares can offer considerable growth potential if they are supported by strong financial data and well -founded basics. In this article we examine several promising Penny shares that stand out for their balance sheet resilience and the potential for impressive returns.

Top 10 Penny shares in the USA

name	Stock price	Market capitalization	Financial health rating
BAB (OTCPK: Babb)	$ 0.860025	$ 6.53 m	★★★★earch
Safe Bulkers (NYSE: SB)	$ 3.71	$ 400.14 m	★★★★ ☆itch
Quantum group (Nasdaqgm: QSG)	$ 3.08	$ 121.65 m	★★★★earch
Cooperative of the golden producers (OTCPK: ggro.u)	$ 4.50	$ 67.38 m	★★★★earch
Imperial Petroleum (Nasdaqcm: IMPP)	$ 2.38	$ 73.1m	★★★★earch
Permianville Royalty Trust (NYSE: PVL)	$ 1.52	$ 48,18m	★★★★earch
Tuya (Nyse: Tuya)	$ 3.52	$ 1.95b	★★★★earch
CBAK Energy Technology (NASDAQCM: CBAT)	$ 0.88	$ 76.36 m	★★★★★ ☆
PhX minerals (NYSE: PHX)	$ 3.77	$ 141.68 m	★★★★★ ☆
Tetra Technologies (NYSE: TTI)	$ 3.39	$ 454.11m	★★★★ ☆itch

Click here to display the full list of 749 shares from our US Penny Stocks screener.

Let us examine several outstanding options from the results in the screen.

Simply Wall ST Financial Health Rating: ★★★★earch

Overview: Amylyx Pharmaceuticals, Inc. is a biotechnological company in the commercial stage that focuses on the development of treatments for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases with a market capitalization of approximately $ 204.93 million.

Operations: Amylyx Pharmaceuticals, Inc. is currently not reporting different sales segments.

Market capitalization: $ 204.93 m

Amylyx Pharmaceuticals, Inc. with a market capitalization of around $ 204.93 million, navigates financial challenges, as this is still installed and unprofitable. Despite a net loss of $ 301.74 million for 2024, the company maintains a wallet for about 10 months and is debt -free, which offers a certain financial stability. The latest developments include the cancellation of a clinical FDA FDA company for the treatment study and new leaders for managers to strengthen the commercialization efforts. The company submitted shelf registers of over $ 312 million to improve liquidity and to support ongoing initiatives in neurodegenerative diseases.

Simply Wall ST Financial Health Rating: ★★★★ ☆itch

Overview: Yatsen Holding Limited with a market capitalization of 345.02 million US dollars developed and sells beauty products under various brands, including perfect diary and Little Onedine in the People's Republic of China.

Operations: The company's income mainly comes from the People's Republic of China and a total of 3.39 billion CN.

Market capitalization: $ 345.02 m

Yatsen Holding Limited with a market capitalization of $ 345.02 million is faced with financial challenges, since despite the generation of CN income of 3.39 billion yen, this is mainly unprecedented from China. The company reported a net loss of CN ¥ 708.17 million for 2024 and recently the goodwill of $ 55.2 million in the fourth quarter of 2024. Despite these setbacks, Yatsen is debt -free and has short -term assets of 2.3 billion CN, which exceed its liabilities. The management team has experienced with an average term of four years, and the stock trade with a significant discount on the estimated current value compared to their peers.

Simply Wall ST Financial Health Rating: ★★★★earch

Overview: Zevia PBC is a beverage company that develops, markets, markets and sells various carbonated drinks in the USA and Canada with a market capitalization of $ 174.22 million.

Operations: The company's turnover results exclusively from its non -alcoholic beverage segment of $ 155.05 million.

Market capitalization: $ 174.22 m

Zevia PBC with a market capitalization of $ 174.22 million reported sales of $ 155.05 million for 2024, which contradicted a decline compared to the previous year. Although the company exceeds the short and long-term liabilities of $ 61.9 million in the amount of USD 61.9 million, which exceeded both short and long-term liabilities, which exceed both short and long-term liabilities, the management team has recently been relatively new. Zevia's share is very volatile, but is a good value compared to colleagues in the industry.

Summarize everything

• Switch off more gemstones! Our American Penny Stocks Screener have discovered 746 other companies that they can explore. Click here to present our professionally curated list of 749 US Penny shares.
• Have you diversified in these companies? Use the performance of Simply Wall St's portfolio to keep an eye on market movements that influence your investments.
• Invested more intelligently with the free Simply Wall St app, which give detailed insights into all stock market markets around the world.

Interested in other options?

This article by Simply Wall Street is a general nature. We offer comments based on historical data and analyst forecasts that only use an impartial methodology, and our articles are not intended as financial advice. It is not a recommendation to buy or sell shares, and does not take into account your goals or your financial situation. We would like to use a long -term focused analysis by basic data. Note that our analysis may not take into account the latest record -sensitive announcements or qualitative material. Simply Wall Street has no position in the stocks mentioned.

Have feedback on this article? Worried about the content? Make sure you contact us. Alternatively, send an email to Redaktionsteam@simplywallst.com